Neogen Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Neogen Corporation (NEOG) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $2.20 per share for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-07-30
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2022-08-31 was $8.49.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2020-08-31 was $15.56, a 4.36% increase year-over-year.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2019-08-31 was $14.91.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2013-08-31 was $14.65.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2026 was $2.20, a 55.65% decline from fiscal 2025.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $4.96, a 17.06% decline from fiscal 2024.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $5.98, a 29.72% increase from fiscal 2023.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $4.61, a 45.70% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | $2.20 10-K · filed 2026-07-30 | ||||||
| 2025-05-31 | $4.96 10-K · filed 2026-07-30 | ||||||
| 2024-05-31 | $5.98 10-K · filed 2026-07-30 | ||||||
| 2023-05-31 | $4.61 10-K · filed 2025-07-30 | ||||||
| 2022-11-30 | $4.59 10-Q · filed 2023-01-09 | ||||||
| 2022-08-31 | $8.49 10-Q · filed 2022-09-30 | ||||||
| 2022-05-31 | $8.49 10-K · filed 2024-07-30 | ||||||
| 2022-02-28 | $9.54 10-Q · filed 2022-04-01 | ||||||
| 2021-11-30 | $9.54 10-Q · filed 2023-01-09 | $7.71 10-Q · filed 2021-12-30 | |||||
| 2021-05-31 | $7.71 10-K · filed 2023-08-15 | ||||||
| 2021-02-28 | $7.71 10-Q · filed 2022-04-01 | $15.41 10-Q · filed 2021-03-31 | |||||
| 2020-11-30 | $15.41 10-Q · filed 2020-12-29 | ||||||
| 2020-08-31 | $15.56 10-Q · filed 2020-09-30 | ||||||
| 2020-05-31 | $7.78 10-K · filed 2022-07-27 | $15.56 10-K · filed 2020-07-30 | |||||
| 2020-02-29 | $15.56 10-Q · filed 2021-03-31 | ||||||
| 2019-11-30 | $15.56 10-Q · filed 2020-12-29 | ||||||
| 2019-08-31 | $14.91 10-Q · filed 2019-09-26 | ||||||
| 2019-05-31 | $7.46 10-K · filed 2021-07-30 | $14.91 10-K · filed 2019-07-30 | |||||
| 2018-05-31 | $14.47 10-K · filed 2020-07-30 | ||||||
| 2017-05-31 | $11.89 10-K · filed 2019-07-30 | $15.86 10-K · filed 2017-07-28 | |||||
| 2016-05-31 | $13.11 10-Q · filed 2017-03-31 | ||||||
| 2015-05-31 | $11.91 10-K · filed 2017-07-28 | ||||||
| 2014-05-31 | $9.87 10-K · filed 2016-07-29 | ||||||
| 2014-02-28 | $9.87 10-Q · filed 2014-04-04 | ||||||
| 2013-11-30 | $9.87 10-Q · filed 2014-01-09 | ||||||
| 2013-08-31 | $14.65 10-Q · filed 2013-09-30 | ||||||
| 2013-05-31 | $9.21 10-K · filed 2015-07-30 | $13.81 10-K · filed 2013-07-30 | |||||
| 2013-02-28 | $13.81 10-Q · filed 2013-03-28 | ||||||
| 2012-11-30 | $13.81 10-Q · filed 2012-12-28 | ||||||
| 2012-05-31 | $6.94 10-K · filed 2014-07-30 | $10.41 10-K · filed 2012-07-30 | |||||
| 2011-08-31 | $8.66 10-Q · filed 2011-09-30 | ||||||
| 2011-05-31 | $8.66 10-K · filed 2013-07-30 | ||||||
| 2010-05-31 | $6.35 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |